A Capacitance and Transepidermal Water Loss Test to Determine the Ability of Sunscreen to Moisturize Skin

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00368563
Recruitment Status : Completed
First Posted : August 24, 2006
Last Update Posted : February 11, 2009
Information provided by:
Loreal USA

Brief Summary:
To evaluate the ability of 2 Helioblock SX Cream formulations to moisturize skin using capacitance and transepidermal water loss methodology

Condition or disease Intervention/treatment Phase
Dry Skin Drug: Helioblock SX Phase 2 Phase 3

Study Type : Interventional  (Clinical Trial)
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single
Study Start Date : August 2006
Actual Primary Completion Date : October 2006
Actual Study Completion Date : October 2006

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 55 Years   (Adult)
Sexes Eligible for Study:   All

Inclusion Criteria:

  • Healthy,male or female subjects 18 years to 55 years of age, with a minimum Stanfield score at baseline of "2" at the forearm sites intended to be assessed in the study
  • Female subjects of childbearing potential using a reliable form of contraception during the course of the study(oral contraceptive pill, intrauterine device, bilateral tubal ligation, abstinence, or other reliable forms at the discretion of the Investigator.) or of non childbearing potential(i.e.,post-menopausal(one year without menstrual period), hysterectomy or bilateral ovariectomy)
  • Subjects who have read, understood and signed an informed consent
  • Subjects who are willing and capable of cooperating to the extent and degree required by the protocol
  • Absence of any visible skin diseases which might be confused with a skin reaction from the test material

Exclusion Criteria:

  • Subjects with a condition, or in a situation, which in the Investigator's or Sub-Investigator's opinion, may suggest a significant hazard for the subject, may confound the study results, or may interfere with the subject's participation in the study.
  • Subjects with known sensitivities to any of the study preparations or to other skin care products
  • Subjects who have participated in a clinical research study, including consumer products studies, within the last 30 days prior to enrollment
  • Subjects who are currently receiving medication(prescription or OTC) that in the opinion of the Investigator may interfere with the evaluations made in this study (e.g.vasoactive substances)
  • Pregnant or nursing females or women who are planning to get pregnant during the study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00368563

United States, Arizona
Hill Top Research
Scottsdale, Arizona, United States, 85251
Sponsors and Collaborators
Loreal USA
Principal Investigator: Linda Oddo, B.S. Hill Top Research Identifier: NCT00368563     History of Changes
Other Study ID Numbers: PEN.1010.02
First Posted: August 24, 2006    Key Record Dates
Last Update Posted: February 11, 2009
Last Verified: February 2009